{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:00:38Z","timestamp":1772118038565,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Healthy Ageing Research Centre","award":["REGPOT-2012-2013-1, 7FP"],"award-info":[{"award-number":["REGPOT-2012-2013-1, 7FP"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.dsx.2014.09.020","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:38:10Z","timestamp":1412995090000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy"],"prefix":"10.1016","volume":"8","author":[{"given":"Adam","family":"Wysoki\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2014.09.020_bib0005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.19.9.920","article-title":"The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group","volume":"19","author":"Fontbonne","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2014.09.020_bib0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/0140-6736(92)92633-Q","article-title":"Insulin resistance: an adaptation for weight maintenance","volume":"340","author":"Eckel","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2014.09.020_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/endo-124-1-410","article-title":"Testosterone raises neuropeptide-Y concentration in selected hypothalamic sites and in vitro release from the medial basal hypothalamus of castrated male rats","volume":"124","author":"Sahu","year":"1989","journal-title":"Endocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.dsx.2014.09.020_bib0020","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.dsx.2014.09.020_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2014.09.020_bib0030","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2014.09.020_bib0035","first-page":"e07","article-title":"Addressing nonresponse in schizophrenia","volume":"73","author":"Kane","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1192\/bjp.182.6.505","article-title":"Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK","volume":"182","author":"Duggan","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","article-title":"Mortality in current and former users of clozapine","volume":"8","author":"Walker","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.dsx.2014.09.020_bib0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/pds.1325","article-title":"Mortality in schizophrenia","volume":"15","author":"Auquier","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.dsx.2014.09.020_bib0055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2014.09.020_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.schres.2012.11.016","article-title":"Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone","volume":"143","author":"Manu","year":"2013","journal-title":"Schizophr Res"},{"issue":"Suppl. 23","key":"10.1016\/j.dsx.2014.09.020_bib0070","first-page":"30","article-title":"Hyperglycemia associated with the use of atypical antipsychotics","volume":"62","author":"Lindenmayer","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000176061","article-title":"Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry","volume":"1","author":"Bosy-Westphal","year":"2008","journal-title":"Obes Facts"},{"key":"10.1016\/j.dsx.2014.09.020_bib0080","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dsx.2014.09.020_bib0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2013 a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2014.09.020_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-1781(01)00234-7","article-title":"Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate","volume":"101","author":"Fontaine","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.dsx.2014.09.020_bib0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0002-9343(01)01000-2","article-title":"Clozapine-associated diabetes","volume":"111","author":"Koller","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.dsx.2014.09.020_bib0100","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archpsyc.58.12.1172","article-title":"Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach","volume":"58","author":"Lund","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4088\/JCP.v59n0604","article-title":"Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications","volume":"59","author":"Hagg","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1176\/appi.ajp.161.2.361","article-title":"A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance","volume":"161","author":"Howes","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4088\/JCP.v65n1009","article-title":"The effect of clozapine on factors controlling glucose homeostasis","volume":"65","author":"Howes","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(01)03026-8","article-title":"Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine","volume":"923","author":"Ardizzone","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.dsx.2014.09.020_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(98)00092-X","article-title":"Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells","volume":"23","author":"Dwyer","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0135","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v66n1117","article-title":"Undiagnosed hyperglycemia in patients treated with atypical antipsychotics","volume":"66","author":"Sernyak","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.prp.2013.09.010","article-title":"Chronic effects of clozapine administration on insulin resistance in rats: Evidence for adverse metabolic effects","volume":"210","author":"El-Seweidy","year":"2013","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.dsx.2014.09.020_bib0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v60n1112","article-title":"Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses","volume":"60","author":"Melkersson","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2014.09.020_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MAJ.0b013e31826485de","article-title":"Accuracy of anthropometric parameters in identification of high-risk patients predicted with cardiovascular risk models","volume":"346","author":"Esteghamati","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.dsx.2014.09.020_bib0155","first-page":"121","article-title":"The associations between obesity, adipose tissue distribution and disease","volume":"723","author":"Bjorntorp","year":"1988","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.dsx.2014.09.020_bib0160","first-page":"1295","article-title":"Correlation of the serum insulin and the serum uric acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus","volume":"7","author":"Gill","year":"2013","journal-title":"J Clin Diagn Res"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T12:55:05Z","timestamp":1538139305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402114000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1871402114000976"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2014.09.020","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2014.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Diabetes India. Published by Diabetes India All rights reserved.","name":"copyright","label":"Copyright"}]}}